Editorial: Antiviral drug discovery against pathogens of pandemic concern: Advancements in target site identification and structure-based drug development

• Krishna M. Padmanabha Das,
• Krishna M. Padmanabha Das

Affiliations

Krishna M. Padmanabha Das

Department of Biological Chemistry and Molecular Pharmacology (BCMP), Harvard Medical School, Boston, MA, United States

Krishna M. Padmanabha Das

Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States